Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2026-01-02 @ 3:34 AM
Study NCT ID:
NCT01516450
Status:
COMPLETED
Last Update Posted:
2017-06-12
First Post:
2011-12-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Japanese phase1 Study of Belimumab (IV vs SC)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2012-04-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-21
First Submit QC Date:
None
Study First Post Date:
2012-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-09
Last Update Post Date:
2017-06-12
Last Update Post Date Type:
ACTUAL